Active	Status	Sponsor type	Region	Phase	Filter
2 Active 147 Inactive 149 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Scleroderma, Systemic
NCT01374282: Post Marketing Surveillance Study of Cuprimine	No Longer Available	N/A		RoW	Cuprimine (penicillamine)	Merck Sharp & Dohme LLC	Scleroderma
NCT02264405: Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study	Recruiting	N/A	50	Europe	Autologous HSCT	European Group for Blood and Marrow Transplantation	Autoimmune Diseases	12/15	12/17

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Scleroderma, Systemic
NCT01374282: Post Marketing Surveillance Study of Cuprimine	No Longer Available	N/A		RoW	Cuprimine (penicillamine)	Merck Sharp & Dohme LLC	Scleroderma
NCT02264405: Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study	Recruiting	N/A	50	Europe	Autologous HSCT	European Group for Blood and Marrow Transplantation	Autoimmune Diseases	12/15	12/17